How is AI transforming cancer care? UF researchers analyze a decade of clinical trials
The research team provided a snapshot of how AI may improve and personalize cancer care.
The research team provided a snapshot of how AI may improve and personalize cancer care.
In an OncLive interview, Carma L. Bylund, PhD, discussed a pilot study on a fellowship program for clinical trial communication skills.
The Phase 1 clinical trial is expected to enroll up to 18 children between 4 and 18 years old with pediatric high-grade gliomas.
Tuo Lin, Ph.D., aims to strengthen his collaboration skills in designing early-phase and pragmatic oncology trials.
At the UF Health Cancer Center, researchers and doctors are not just focused on today’s care. They’re looking to improve it for patients tomorrow.
Findings of the trial represent the biggest breakthrough in childhood cancer treatment in decades, and the drug has already become the new global standard of care.
The UF Health Cancer Center has successfully integrated an oncology clinical trial nurse navigator into its clinical research infrastructure.
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
The study seeks to address anxiety-induced delays in radiation treatment.
A clinical trial offered at UF Health provided one family something that had been in short supply as they navigated the deadliest skin cancer: hope.